Audeara Ltd. (AU:AUA)
ASX:AUA
Want to see AU:AUA full AI Analyst Report?
Top Page
Audeara Ltd.
(Sydney:AUA)
Select Model
Select Model
Rating:41Neutral
Price Target:
AU$0.03
▼(-51.67% Downside)
Action:Reiterated
Date:05/02/26
Overall score is driven primarily by weak financial performance (declining revenue, ongoing losses, and negative operating/free cash flow). Technicals add further pressure with a clear downtrend (price below key moving averages and negative MACD), while oversold readings only modestly offset the bearish setup. Valuation provides limited support because the negative P/E stems from losses and there is no dividend yield data.
Positive Factors
Market positioning
Audeara's positioning across health technology and consumer/professional audio targets structurally growing hearing-health demand. Serving both end consumers and B2B partners supports diversified distribution, product differentiation and recurring service opportunities that can persist over months.
Negative Factors
Declining revenue
A near 10% revenue decline weakens scale economics and makes fixed-cost absorption harder. Persistent top-line contraction reduces leverage on gross margin, constrains reinvestment in growth channels, and requires clear remediation (product, pricing or channel fixes) to restore sustainable growth.
Read all positive and negative factors
Positive Factors
Negative Factors
Market positioning
Audeara's positioning across health technology and consumer/professional audio targets structurally growing hearing-health demand. Serving both end consumers and B2B partners supports diversified distribution, product differentiation and recurring service opportunities that can persist over months.
Read all positive factors
Audeara Ltd. (AUA) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$5.61M
Dividend YieldN/A
Average Volume (3M)183.49K
Price to Earnings (P/E)―
Beta (1Y)0.23
Revenue Growth17.44%
EPS Growth61.64%
CountryAU
EmployeesN/A
SectorTechnology
Sector Strength88
IndustryConsumer Electronics
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding180,976,550
10 Day Avg. Volume498,101
30 Day Avg. Volume183,491
Financial Highlights & Ratios
PEG Ratio1.17
Price to Book (P/B)2.91
Price to Sales (P/S)0.99
P/FCF Ratio-1.93
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Audeara Ltd. Business Overview & Revenue Model
Company Description
Audeara Limited, a hearing health technology company, engages in the development and sale of personalized listening products in Australia and North America. It provides A01 and A-02 Bluetooth headphones; A-02 TV bundles; and BT01 wireless transc...
How the Company Makes Money
Audeara makes money primarily through sales of its hearing and audio solutions, which may include (i) product revenue from the sale of hardware (e.g., headphones or hearing-related devices) and (ii) revenue associated with software-enabled feature...
Audeara Ltd. Financial Statement Overview
Summary
Income Statement
35
Negative
Balance Sheet
45
Neutral
Cash Flow
40
Negative
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.94M | 3.79M | 3.19M | 2.91M | 2.07M | 1.12M |
| Gross Profit | 452.03K | 1.36M | 943.12K | 1.14M | 946.11K | 510.33K |
| EBITDA | -2.24M | -2.90M | -2.75M | -3.80M | -3.07M | -1.08M |
| Net Income | -1.00M | -1.79M | -1.60M | -3.74M | -2.95M | -1.25M |
Balance Sheet | ||||||
| Total Assets | 3.75M | 4.30M | 4.89M | 4.73M | 5.49M | 6.57M |
| Cash, Cash Equivalents and Short-Term Investments | 755.32K | 1.42M | 1.27M | 2.62M | 2.87M | 5.74M |
| Total Debt | 521.46K | 1.12M | 112.18K | 210.74K | 275.11K | 67.60K |
| Total Liabilities | 2.88M | 3.01M | 3.28M | 1.57M | 1.41M | 665.76K |
| Stockholders Equity | 871.52K | 1.29M | 1.61M | 3.17M | 4.08M | 5.91M |
Cash Flow | ||||||
| Free Cash Flow | -1.06M | -1.95M | -1.34M | -2.98M | -3.78M | -1.11M |
| Operating Cash Flow | -914.91K | -1.81M | -1.33M | -2.97M | -3.58M | -1.08M |
| Investing Cash Flow | -157.56K | -149.02K | -8.47K | -16.00K | -229.26K | -23.71K |
| Financing Cash Flow | 104.26K | 2.08M | -10.88K | 2.74M | 939.73K | 7.10M |
Audeara Ltd. Technical Analysis
Negative
0.06
Price Trends
0.05
Negative
0.06
Negative
0.05
Negative
Market Momentum
>-0.01
Negative
10.60
Positive
37.78
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:AUA, the sentiment is Negative. The current price of 0.06 is above the 20-day moving average (MA) of 0.04, above the 50-day MA of 0.05, and above the 200-day MA of 0.05, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 10.60 is Positive, neither overbought nor oversold. The STOCH value of 37.78 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:AUA.
Audeara Ltd. Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
50 Neutral | AU$5.06M | 0.92 | 26.81% | ― | -17.34% | ― | |
41 Neutral | AU$5.61M | -4.70 | -92.37% | ― | 17.44% | 61.64% | |
41 Neutral | AU$5.92M | -0.53 | 209.30% | ― | -13.81% | -37.77% | |
39 Underperform | AU$14.43M | -1.67 | -432.52% | ― | -3.97% | 32.71% |
* Technology Sector Average
AU:AUA
Audeara Ltd.
0.03
<0.01
7.69%
AU:DWG
IXUP Ltd.
0.12
-0.02
-17.24%
AU:X2M
X2M Connect Limited
0.01
-0.01
-50.00%
AU:BCC
Beam Communications Holdings Limited
0.06
0.03
90.32%
Audeara Ltd. Corporate Events
Audeara Co-founder and CTO to Step Down as Hearing Tech Group Enters New Growth Phase
Apr 23, 2026
Audeara has announced that co-founder and Chief Technology Officer Alex Afflick will resign from his executive role on 1 July 2026, following a structured transition period to maintain continuity. The board has signalled a need for a different tec...
Audeara Secures Exclusive Australian Rights to ShokzHear Open-Ear Classroom Listening Device
Apr 15, 2026
Audeara has secured exclusive Australian distribution rights from Shokz Health Global’s ShokzHear division for a customised assistive listening device, OpenLearn Small by ShokzHear, adapted specifically for local educational settings. The pr...
Audeara Seeks ASX Quotation for Additional Ordinary Shares
Apr 14, 2026
Audeara Ltd. has applied for quotation on the ASX of 87,401 new ordinary fully paid shares, with an issue date of 14 April 2026. The additional shares arise from the exercise or conversion of existing options or other convertible securities, modes...
Audeara posts second straight quarter of positive cash flow as Auracast expansion gathers pace
Apr 13, 2026
Audeara reported a second consecutive quarter of positive operating cash flow, generating $359,000 in Q3 FY26 and $380,000 year to date, alongside unaudited group revenue of $1 million for the quarter and $3.9 million year to date. Cash receipts f...
Audeara expands Auracast platform with new Clinico deals and BT-03 rollout
Mar 8, 2026
Audeara has secured purchase orders from Taiwan-based Clinico Inc., initiating three new white-label commercial programs that will see Auracast-enabled devices, packaging, accessories and a programming tool sold under the Clinico brand. The initia...
Audeara lifts revenue and narrows loss but faces going-concern uncertainty
Feb 25, 2026
Audeara Limited reported a 63.76% increase in revenue to $2.95 million for the half year to 31 December 2025, while halving its loss from ordinary activities after tax to $593,443 compared with the prior corresponding period. The company’s c...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.